Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-17-012816

Director acquired 2,537,110 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
OrbiMed Israel GP Ltd. Director 2017-05-09 Grant or award +2,537,110 2,537,110 I: show line 1 in the form
Loading xslF345X03/doc4.xml…